San Diego Anti-aging medicine and family practice located in Encinitas CA, Center for Age Management

Optimize Your Health
Center for Age Management

317 N. El Camino Real, Suite 206
Encinitas, CA 92024
USA View Map

Phone: 760-633-1315

 

Mon - Thur: 9am to 5pm
Lunch: 12pm to 1:30pm
Friday: 9am to 12pm
On Fridays, we will have limited staff. You may leave a message and it will be our pleasure to return your call. Any prescriptions, questions or concerns that you have, we will be happy to assist you Monday - Thursday.

Serving other neighboring cities: La Costa, Solana Beach, Rancho Santa Fe, Del Mar, San Marcos, Carlsbad, La Jolla, and San Diego County, CA.

e2 and Stroke

Reuters Health Information 2007. © 2007 Reuters Ltd.

Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

NEW YORK (Reuters Health) Mar 26 – The timing of estrogen therapy after menopause appears to play a key role in determining whether this intervention will protect against or facilitate damage from a stroke, findings from an animal study suggest. This may help explain seemingly discordant findings from previous studies.

Recent data from the Women’s Health Initiative (WHI) and other studies suggested that estrogen therapy offered no benefit against stroke or even increased the risk in postmenopausal women. However, years before these studies even began, there were numerous reports describing a neuroprotective effect for estrogen therapy.

In the present study, Dr. Phyllis M. Wise, from the University of Washington in Seattle, and colleagues assessed the impact that the timing of estrogen therapy has on stroke damage in ovariectomized mice. The mice were treated with estrogen therapy either immediately after ovariectomy or 10 weeks later. At 20 weeks of age, ischemic stroke was experimentally induced.

The investigators’ findings appear in the March 26th Early Edition of the Proceedings of the National Academy of Sciences.

The researchers found that animals treated with immediate estrogen therapy experienced much less brain damage than did those who received delayed estrogen therapy.

“These results demonstrate that a prolonged period of hypoestrogenicity disrupts both neuroprotective and antiinflammatory actions of 17beta-estradiol. Our findings may help to explain the results of the WHI that reported no beneficial effect of estrogen therapy against stroke because the majority of the subjects initiated estrogen therapy after an extended period of hypoestrogenicity,” the authors conclude.

Proc Natl Acad Sci USA 2007.